Breaking News Instant updates and real-time market news.

OBSV

ObsEva

$12.52

0.25 (2.04%)

, ABBV

AbbVie

$97.29

-0.73 (-0.74%)

07:51
08/29/18
08/29
07:51
08/29/18
07:51

AbbVie study of elagolix reduces risk for ObsEva, says H.C. Wainwright

H.C. Wainwright analyst Raghuram Selvaraju believes AbbVie's (ABBV) long-term safety extension study of elagolix in women with uterine fibroids reduces risk for ObsEva (OBSV). The long-term efficacy for elagolix should bode well for future development of ObsEva's linzagolix in uterine fibroids, since both drugs are gonadotropin-releasing hormone receptor antagonists and have thus far shown comparable potency in clinical studies, Selvaraju tells investors in a research note. The analyst reiterates a Buy rating on ObsEva with a $44 price target.

OBSV

ObsEva

$12.52

0.25 (2.04%)

ABBV

AbbVie

$97.29

-0.73 (-0.74%)

  • 04

    Sep

  • 05

    Sep

  • 12

    Sep

OBSV ObsEva
$12.52

0.25 (2.04%)

08/07/18
08/07/18
INITIATION

On The Fly: Top five analyst initiations
Catch up on today's top five analyst initiations with this list compiled by The Fly: 1. Broadcom (AVGO) reinstated with an Overweight at Barclays. 2. ObsEva (OBSV) initiated with an Outperform at Wedbush. 3. Deciphera (DCPH) initiated with a Buy at Canaccord. 4. Alliance Data (ADS) assumed with a Buy at Jefferies. 5. Hermes (HESAY) initiated with an Equal Weight at Morgan Stanley. This list is just a portion of The Fly's analyst coverage. To see The Fly's full Street Research coverage, click here.
08/08/18
HCWC
08/08/18
NO CHANGE
Target $44
HCWC
Buy
ObsEva price target raised to $44 from $30 at H.C. Wainwright
H.C. Wainwright analyst Raghuram Selvaraju raised his price target for ObsEva (OBSV) to $44 based on the disclosed pricing for AbbVie's (ABBV) Orilissa, the fgonadotropin-releasing hormone receptor antagonist for endometriosis and uterine fibroids. ObsEva management had previously guided to the cost of GnRH receptor antagonist therapy at $15 per day, about $450 per month, and the proposed monthly cost of Orilissa at $845 "appears to be comfortably above this level," Selvaraju tells investors in a research note. As such, the analyst elected to revise his pricing assumptions upward for ObsEva's linzagolix to reflect a daily cost of $25. He keeps a Buy rating on ObsEva shares.
08/15/18
LEER
08/15/18
INITIATION
Target $25
LEER
Outperform
ObsEva resumed with an Outperform at Leerink
Leerink analyst Ami Fadia resumed coverage of ObsEva with an Outperform rating and $25 price target. The analyst believes that at current levels the stock does not fully reflect the commercial potential of its lead product linzagolix, which she believes can reach over $1B in peak sales, its additional women's health pipeline, and its more than $100M cash balance that can fund operation into 1H20, by which time she expects to get positive UF Phase 3 data readout for linzagolix.
08/15/18
08/15/18
INITIATION

On The Fly: Top five analyst initiations
Catch up on today's top five analyst initiations with this list compiled by The Fly: 1. Cision (CISN) initiated with an Outperform at William Blair. 2. ObsEva (OBSV) resumed with an Outperform at Leerink. 3. Idera Pharmaceuticals (IDRA) resumed with an Overweight at JPMorgan. 4. DTE Energy (DTE) initiated with an Equal Weight at Barclays. 5. Tellurian (TELL) initiated with an Outperform at Baird. This list is just a portion of The Fly's analyst coverage. To see The Fly's full Street Research coverage, click here.
ABBV AbbVie
$97.29

-0.73 (-0.74%)

07/24/18
SBSH
07/24/18
NO CHANGE
SBSH
Buy
Citi says Myovant may have $102 upside if relugolix priced at parity to elagolix
After AbbVie (ABBV) and Neurocrine Biosciences (NBIX) announced that the FDA approved elagolix and Neurocrine said the list price has been set at $28 per day, Citi analyst Robyn Karnauskas noted that she currently models Myovant Sciences' (MYOV) relugolix priced at $10 per day. Modeling relugolix pricing at parity to elagolix and assuming a gross-to-net of 100% would lead to a fair value estimate for Myovant of $146, or the equivalent of $102 of upside from her current price target of $44, Karnauskas stated. The analyst, who models a split market between relugolix and elagolix in endometriosis, keeps a Buy rating on Myovant shares.
07/27/18
PIPR
07/27/18
NO CHANGE
Target $100
PIPR
Neutral
Worries about AbbVie's Humira keep Piper Jaffray on sidelines
Piper Jaffray analyst Christopher Raymond said he finds "little to quibble with" in AbbVie's Q2 report, but also noted that while its FY18 EPS guidance was raised, its revenue guidance actually came down slightly. Raymond, who continues to worry that consensus does not fully factor in the extent of ex-U.S. Humira pressure or the further pressure from co-pay accumulator programs in the U.S., prefers to stay on the sidelines and keeps a Neutral rating on the shares. He also lowered his price target on AbbVie to $100 from $105.
08/22/18
PIPR
08/22/18
NO CHANGE
Target $130
PIPR
Overweight
AbbVie decision suggests positive Argenx data, says Piper Jaffray
AbbVie's (ABBV) decision to exercise an exclusive option to license Argenx's (ARGX) anti-GARP antibody, ARGX-115, suggests positive preclinical data, Piper Jaffray analyst Edward Tenthoff tells investors in a research note. The analyst looks for investigational new drug application filing plans this year. He reiterates an Overweight rating on shares of Argenx with a $130 price target.

TODAY'S FREE FLY STORIES

TMUS

T-Mobile

$72.68

-0.67 (-0.91%)

, S

Sprint

$5.61

-0.01 (-0.18%)

07:39
04/26/19
04/26
07:39
04/26/19
07:39
Recommendations
T-Mobile, Sprint analyst commentary  »

T-Mobile price target…

TMUS

T-Mobile

$72.68

-0.67 (-0.91%)

S

Sprint

$5.61

-0.01 (-0.18%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Apr

07:38
04/26/19
04/26
07:38
04/26/19
07:38
Conference/Events
The National Press Club to host a luncheon meeting »

Panera Bread Founder…

PRO

Pros Holdings

$45.06

-0.25 (-0.55%)

07:37
04/26/19
04/26
07:37
04/26/19
07:37
Recommendations
Pros Holdings analyst commentary  »

ProsHoldings price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 07

    May

PFPT

Proofpoint

$131.35

3.56 (2.79%)

07:36
04/26/19
04/26
07:36
04/26/19
07:36
Recommendations
Proofpoint analyst commentary at KeyBanc »

Proofpoint price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 05

    Jun

  • 13

    Nov

CELG

Celgene

$93.93

0.82 (0.88%)

, XLRN

Acceleron

$41.19

0.62 (1.53%)

07:36
04/26/19
04/26
07:36
04/26/19
07:36
Hot Stocks
Celgene, Acceleron announces submission of luspatercept MAA to EMA »

Celgene Corporation…

CELG

Celgene

$93.93

0.82 (0.88%)

XLRN

Acceleron

$41.19

0.62 (1.53%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    Apr

  • 04

    May

  • 07

    May

  • 18

    May

  • 31

    May

  • 27

    Jun

  • 03

    Sep

ACB

Aurora Cannabis

$9.07

-0.045 (-0.49%)

07:36
04/26/19
04/26
07:36
04/26/19
07:36
Hot Stocks
Aurora Cannabis makes $10M equity investment in EnWave »

To further cement the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ANET

Arista Networks

$318.30

-7.02 (-2.16%)

07:35
04/26/19
04/26
07:35
04/26/19
07:35
Recommendations
Arista Networks analyst commentary at Nomura Instinet »

Arista Networks price…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 02

    May

  • 05

    Jun

  • 10

    Jun

AAL

American Airlines

$33.36

-0.64 (-1.88%)

07:35
04/26/19
04/26
07:35
04/26/19
07:35
Earnings
American Airlines lowers FY19 adj. EPS view to $4.00-$6.00 from $5.50-$7.50 

Consensus $5.63.

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Apr

  • 21

    May

  • 29

    May

  • 12

    Jun

FB

Facebook

$193.23

10.59 (5.80%)

, INTC

Intel

$57.59

-1.13 (-1.92%)

07:35
04/26/19
04/26
07:35
04/26/19
07:35
Options
Unusual call flow in option market yesterday »

Notable call activity was…

FB

Facebook

$193.23

10.59 (5.80%)

INTC

Intel

$57.59

-1.13 (-1.92%)

MRVL

Marvell

$25.42

-0.03 (-0.12%)

APC

Anadarko

$71.76

0.35 (0.49%)

OXY

Occidental Petroleum

$61.81

-0.19 (-0.31%)

ZNGA

Zynga

$5.47

-0.115 (-2.06%)

GT

Goodyear Tire

$19.56

-0.54 (-2.69%)

CARA

Cara Therapeutics

$19.39

0.335 (1.76%)

RSG

Republic Services

$79.46

0.16 (0.20%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Apr

  • 28

    Apr

  • 01

    May

  • 05

    May

  • 07

    May

  • 07

    May

  • 08

    May

  • 10

    May

  • 14

    May

  • 16

    May

  • 17

    May

  • 22

    May

  • 29

    May

  • 30

    May

  • 03

    Jun

  • 05

    Jun

  • 25

    Jul

  • 13

    Nov

07:34
04/26/19
04/26
07:34
04/26/19
07:34
Conference/Events
FDA Anti-Microbial Drugs Advisory Committee to hold a meeting »

The Committee discusses…

AVGO

Broadcom

$311.99

-2.11 (-0.67%)

, QRVO

Qorvo

$77.33

0.09 (0.12%)

07:34
04/26/19
04/26
07:34
04/26/19
07:34
Recommendations
Broadcom, Qorvo analyst commentary  »

Broadcom price target…

AVGO

Broadcom

$311.99

-2.11 (-0.67%)

QRVO

Qorvo

$77.33

0.09 (0.12%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 07

    May

AAL

American Airlines

$33.36

-0.64 (-1.88%)

07:33
04/26/19
04/26
07:33
04/26/19
07:33
Earnings
American Airlines reports Q1 adj. EPS 52c, consensus 51c »

Reports Q1 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Apr

  • 21

    May

  • 29

    May

  • 12

    Jun

QRVO

Qorvo

$77.33

0.09 (0.12%)

, AVGO

Broadcom

$311.99

-2.11 (-0.67%)

07:32
04/26/19
04/26
07:32
04/26/19
07:32
Downgrade
Qorvo, Broadcom rating change  »

Qorvo downgraded to…

QRVO

Qorvo

$77.33

0.09 (0.12%)

AVGO

Broadcom

$311.99

-2.11 (-0.67%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 07

    May

IMAX

Imax

$25.05

0.02 (0.08%)

07:31
04/26/19
04/26
07:31
04/26/19
07:31
Earnings
Imax reports Q1 adjusted EPS 18c, consensus 18c »

Reports Q1 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Apr

  • 15

    May

  • 05

    Jun

AMZN

Amazon.com

$1,902.53

1.81 (0.10%)

07:30
04/26/19
04/26
07:30
04/26/19
07:30
Recommendations
Amazon.com analyst commentary at Barclays »

Amazon.com price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 10

    May

  • 22

    May

  • 03

    Jun

AJG

Arthur J. Gallagher

$82.75

0.68 (0.83%)

07:30
04/26/19
04/26
07:30
04/26/19
07:30
Recommendations
Arthur J. Gallagher analyst commentary at SunTrust »

Arthur J. Gallagher price…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    May

  • 20

    May

SFUN

Fang Holdings

$1.62

0.08 (5.19%)

07:30
04/26/19
04/26
07:30
04/26/19
07:30
Earnings
Breaking Earnings news story on Fang Holdings »

Fang Holdings sees FY18…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Apr

SAVE

Spirit Airlines

$52.91

-5.39 (-9.25%)

07:30
04/26/19
04/26
07:30
04/26/19
07:30
Recommendations
Spirit Airlines analyst commentary at Stephens »

Spirit Airlines issues…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    May

  • 21

    May

  • 12

    Jun

  • 13

    Nov

SWN

Southwestern Energy

$4.03

-0.13 (-3.13%)

, YPF

YPF

$13.70

-0.29 (-2.07%)

07:30
04/26/19
04/26
07:30
04/26/19
07:30
Options
Unusual put flow in option market yesterday »

Notable put activity was…

SWN

Southwestern Energy

$4.03

-0.13 (-3.13%)

YPF

YPF

$13.70

-0.29 (-2.07%)

WAB

Wabtec

$71.41

-5.16 (-6.74%)

MAS

Masco

$37.50

-2.48 (-6.20%)

ODFL

Old Dominion

$152.25

-6.74 (-4.24%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Apr

  • 08

    May

  • 10

    May

  • 10

    May

  • 15

    May

  • 21

    May

  • 21

    May

  • 22

    May

  • 05

    Jun

  • 13

    Nov

AMZN

Amazon.com

$1,902.53

1.81 (0.10%)

07:29
04/26/19
04/26
07:29
04/26/19
07:29
Recommendations
Amazon.com analyst commentary at Wedbush »

Amazon.com price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 10

    May

  • 22

    May

  • 03

    Jun

SFUN

Fang Holdings

$1.62

0.08 (5.19%)

07:28
04/26/19
04/26
07:28
04/26/19
07:28
Earnings
Fang Holdings reports Q4 non-GAAP EPS 2c vs. 5c last year »

Reports Q4 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Apr

APD

Air Products

$199.63

0.13 (0.07%)

07:27
04/26/19
04/26
07:27
04/26/19
07:27
Recommendations
Air Products analyst commentary  »

Air Products price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TSCO

Tractor Supply

$105.09

1 (0.96%)

07:26
04/26/19
04/26
07:26
04/26/19
07:26
Recommendations
Tractor Supply analyst commentary at Wedbush »

Tractor Supply price…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 09

    May

  • 15

    May

  • 25

    Jul

  • 13

    Nov

HFWA

Heritage Financial

$30.77

-0.6 (-1.91%)

07:26
04/26/19
04/26
07:26
04/26/19
07:26
Downgrade
Heritage Financial rating change  »

Heritage Financial…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    May

  • 01

    May

CARO

Carolina Financial

$36.08

-0.83 (-2.25%)

07:25
04/26/19
04/26
07:25
04/26/19
07:25
Downgrade
Carolina Financial rating change at Sandler ONeill »

Carolina Financial…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.